Inhaler Devices (pMDI, DPI): Market Size & Forecast 2026

The global inhaler devices market for pMDI and DPI platforms sits at approximately USD 6.2 billion in 2025 (base year), expanding to a forecast USD 8.9 billion by 2032 on a 5.3% CAGR. The market operates in a structurally tight supply configuration dominated by vertically integrated pharma manufacturers that control both device design and drug formulation. pMDI platforms account for roughly 58% of market value, while DPIs contribute 42%; the pMDI segment carries disproportionate regulatory headwind because hydrofluoroalkane propellants account for roughly 90% of lifecycle CO2-equivalent emissions per device. The reference unit cost for a complete DPI device runs approximately USD 306,500 on a development-and-tooling basis, while a commercial pMDI reference SKU prices at USD 2.75 per finished unit at scale. > **Analyst Take.** The consensus 5.3% CAGR is directionally right but the composi

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.